Editorial comment of defibrillators and guidelines;Commento editoriale A proposito di defibrillatori impiantabili e linee guida

Giornale Italiano di Cardiologia

Volumn 7, Issue 3, 2006, Pages 228-233

  Tavazzi, Luigi ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COST UTILITY ANALYSIS; DEFIBRILLATOR; DRUG EFFICACY; EDITORIAL; HEALTH CARE COST; HEART ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; IMPLANTATION; MEDICARE; META ANALYSIS; MORTALITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PUBLICATION; REIMBURSEMENT; RISK REDUCTION; SECONDARY PREVENTION; SYSTEMATIC REVIEW; TREATMENT INDICATION; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; ECONOMICS; EUROPE; FOLLOW UP; HEART STROKE VOLUME; NOTE; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SUDDEN DEATH; TIME; UNITED STATES; UTILIZATION REVIEW;

CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EUROPE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; META-ANALYSIS; PRACTICE GUIDELINES; PRIMARY PREVENTION; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; STROKE VOLUME; TIME FACTORS; UNITED STATES;

EID: 33645729420     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. Paperini L, Genovesi A, Carluccio M. La morte cardiaca improvvisa: prevenzione, quando opportuno! Da evidence-based medicine a family-based medicine. GIC - G Ital Cardiol 2006; 7: 224-7.
2. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
3. Al-Khatib SM, Sanders GD, Mark DB, et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 2005; 149: 1020-34.
4. Buxton A. Not everyone with an ejection fraction ≤ 30% should receive an implantable cardioverter-defibrillator. Circulation 2005; 111: 2537-42.
5. Moss AJ. Everyone with an ejection fraction ≤ 30% should receive an implantable cardioverter-defibrillator. Circulation 2005; 111: 2542-8.
6. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
7. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2005; 46: e1-e82.
8. Kadish A, Dyer A, Daubert JP, et al, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
9. Theuns DA, Klootwijk PJ, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004; 44: 2362-7.
10. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
11. Kadish A, Mehra M. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation 2005; 111: 3327-35.
12. Medicare Coverage Database 2005. www.cms.hhs.gov/med/ viewdecisionmemo.asp?id=148
13. Swedberg H, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). http://www.escardio.org/knowledge/guidelines/Chronic_Heart_Failure.htm
14. Hohnloser SH, Kuck KH, Dorian P, et al, for the DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481-8.
15. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997; 337: 1569-75.
16. Solomon SD, Zelenkofske S, McMurray JJ, et al, for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005; 352: 2581-8.
17. Swedberg K, for the Writing Committee of the ESC Guidelines on the Diagnosis and Treatment of Chronic Heart Failure. (letter) Eur Heart J 2005; 26: 2473.
18. Cleland JG, Daubert JC, Erdmann E, et al, for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.
19. Bristow MR, Saxon LA, Boehmer J, et al, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.
20. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004; 141: 381-90.
21. Tavazzi L, Tognoni G, Franzosi MG, et al, for the GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004; 6: 635-41.
22. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005; 353: 1471-80.
23. Steinbrook R. The controversy over Guidant's implantable defibrillators. N Engl J Med 2005; 353: 221-4.